Key facts
- Elligint Health’s last known valuation is $14.0M (Jan 2025).
- It has raised $3.2M across 2 recorded rounds; the latest was Early Stage VC ($13.1M) in Dec 2024.
- Notable investors include Labcorp Venture Fund, Edison Partners.
- Elligint Health has filed 3 Form Ds with the SEC, most recently Jun 2025 ($13.1M sold to 56 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Elligint Health
Funding rounds
2 roundsAbout Elligint Health
Operator of a healthcare platform intended to align stakeholders, integrate data, and provide actionable intelligence for whole-person care. The company platform offers data integration, real-time insights, and decision-making tools, enabling healthcare organizations to improve care coordination, enhance outcomes, and support providers, payers, and patients.
- Sector
- Healthcare
- HQ
- Edison, NJ, United States
- Founded
- 2024
- Employees
- 61
- Website
- elliginthealth.com/
- Ownership
- Privately Held (backing)
Elligint Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elligint Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elligint Health in its N-PORT filings yet. We sweep new filings monthly.